Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.188378
0.00 (0.00%)
At close: Jun 5, 2026
Escalon Medical Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 11.45 | 12.05 | 11.98 | 12.18 | 10.7 | 10.47 | |
Revenue Growth (YoY) | -11.60% | 0.54% | -1.63% | 13.80% | 2.21% | 11.40% |
Cost of Revenue | 6.7 | 6.54 | 6.84 | 6.7 | 6.1 | 6.04 |
Gross Profit | 4.75 | 5.51 | 5.15 | 5.48 | 4.61 | 4.43 |
Selling, General & Admin | 4.97 | 4.62 | 4.56 | 4.18 | 4.09 | 3.57 |
Research & Development | 0.67 | 0.75 | 0.69 | 0.82 | 0.99 | 0.89 |
Operating Expenses | 5.64 | 5.38 | 5.25 | 5 | 5.08 | 4.46 |
Operating Income | -0.9 | 0.13 | -0.1 | 0.48 | -0.47 | -0.03 |
Interest Expense | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Interest & Investment Income | - | - | - | - | 0 | 0 |
Other Non Operating Income (Expenses) | -0.05 | -0.01 | - | - | - | 0 |
EBT Excluding Unusual Items | -0.96 | 0.11 | -0.13 | 0.46 | -0.49 | -0.05 |
Other Unusual Items | - | - | - | - | 0.51 | - |
Pretax Income | 1.85 | 0.11 | -0.13 | 0.46 | 0.02 | -0.05 |
Earnings From Continuing Operations | 1.85 | 0.11 | -0.13 | 0.46 | 0.02 | -0.05 |
Net Income | 1.85 | 0.11 | -0.13 | 0.46 | 0.02 | -0.05 |
Preferred Dividends & Other Adjustments | 0.94 | 0.08 | 0.05 | 0.24 | 0.05 | 0.05 |
Net Income to Common | 0.91 | 0.03 | -0.18 | 0.22 | -0.03 | -0.1 |
Net Income Growth | 198.78% | - | - | 2426.55% | - | - |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 15 | 14 | 7 | 14 | 7 | 7 |
Shares Change (YoY) | 16.28% | 92.20% | -45.33% | 82.92% | - | - |
EPS (Basic) | 0.12 | 0.00 | -0.02 | 0.03 | -0.00 | -0.01 |
EPS (Diluted) | 0.12 | 0.00 | -0.02 | 0.03 | -0.00 | -0.01 |
Free Cash Flow | -0.14 | 0.38 | -0.64 | 0.32 | -1.05 | 0.83 |
Free Cash Flow Per Share | -0.01 | 0.03 | -0.09 | 0.02 | -0.14 | 0.11 |
Gross Margin | 41.48% | 45.75% | 42.95% | 45.00% | 43.04% | 42.28% |
Operating Margin | -7.82% | 1.11% | -0.87% | 3.93% | -4.39% | -0.32% |
Profit Margin | 7.99% | 0.23% | -1.48% | 1.82% | -0.31% | -0.99% |
Free Cash Flow Margin | -1.26% | 3.13% | -5.37% | 2.61% | -9.81% | 7.92% |
EBITDA | -0.87 | 0.17 | -0.06 | 0.52 | -0.42 | 0.01 |
EBITDA Margin | -7.57% | 1.42% | -0.49% | 4.30% | -3.94% | 0.11% |
D&A For EBITDA | 0.03 | 0.04 | 0.05 | 0.05 | 0.05 | 0.04 |
EBIT | -0.9 | 0.13 | -0.1 | 0.48 | -0.47 | -0.03 |
EBIT Margin | -7.82% | 1.11% | -0.87% | 3.93% | -4.39% | -0.32% |
Revenue as Reported | 11.45 | 12.05 | 11.98 | 12.18 | 10.7 | 10.47 |
Advertising Expenses | - | - | - | - | - | 0 |